Recent News

• 03.12.2025 - OPRX 4th Quarter 2024 Earnings Conference Call
• 03.12.2025 - OPRX 4th Quarter 2024 Earnings Conference Call
• 03.11.2025 - OptimizeRx Corporation Confirms Receipt of Notice of Director Nominations
• 03.11.2025 - OptimizeRx Corporation Confirms Receipt of Notice of Director Nominations
• 03.10.2025 - OptimizeRx Corporation Appoints Stephen Silvestro as Chief Executive Officer
• 03.10.2025 - OptimizeRx Corporation Appoints Stephen Silvestro as Chief Executive Officer
• 02.27.2025 - OptimizeRx Sets Fourth Quarter and Full Year 2024 Financial Results Conference Call for March 12, 2025, at 8:30 a.m. ET
• 02.27.2025 - OptimizeRx Sets Fourth Quarter and Full Year 2024 Financial Results Conference Call for March 12, 2025, at 8:30 a.m. ET

Recent Filings

• 03.11.2025 - DFAN14A Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material
• 03.11.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 03.10.2025 - 8-K Current report
• 03.10.2025 - EX-99.1 EX-99.1
• 03.10.2025 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership
• 03.04.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.04.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.20.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.20.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.20.2025 - 4 Statement of changes in beneficial ownership of securities